Skip to content
Review

Running title: The plasticity of CAFs in cancer development.

Nov 2026 · Clinica chimica acta; international journal of clinical chemistry · pp. 122960 · 0 citations · 147 references
Medicine

Abstract

Cancer is among the leading causes of death worldwide. The tumor microenvironment is a dynamic, multifaceted milieu where the cancer cells interact with diverse components. Resident stromal cell-derived cancer-associated fibroblasts are central to the crosstalk. There is variability in the origin, phenotype, and function of CAFs, which is influenced by signaling cues from cancer cells and the extracellular matrix. The presence of CAFs in the TME coincides with tumorigenesis, invasion, metastasis, and drug resistance. Many mechanisms are involved, such as metabolic reprogramming of glucose, amino acid, and lipid metabolism. For example, enhanced lactate production can contribute to a glucose-lactate shuttle that supports tumor growth. Dysregulation of normal ECM remodeling leads to a breakdown of the basement membrane, thereby enabling tumor cells to invade. Besides contributing to poor prognosis, CAFs may induce cancer cells to create vascular-like networks. They also recruit immunosuppressive cells and inhibit the immune response. Consequently, deciphering how the different factors affecting the fate and function of CAFs signal and modulate their activities is imperative in fully grasping the complex biology of cancer to seek more effective therapeutic options. By targeting key pathways, surface markers, and conversion of CAFs to a quiescent state, the therapeutic outcome of the treatments for cancers may be improved. In this review, we summarize current knowledge on the biology of cancer-associated fibroblasts (CAFs), highlighting how distinct CAF subtypes defined by markers such as α-SMA, FAP, and MHC II (apCAFs), as well as inflammatory (iCAFs) and myofibroblastic (myCAFs) profiles-modulate extracellular matrix remodeling, metabolism, angiogenesis, immune responses, and metastatic potential. Our detailed review goes beyond explaining the potential of CAFs in developing and progressing cancer and addresses areas of research that could enable the widespread translation of this science for effective cancer therapy. Translational work and well-designed clinical trials will be required to fully transform CAFs from facilitators of resistance to actionable targets.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.